[1]
T. J. Oscanoa, J. Amado, R. Romero-Ortuno, and A. Carvajal, “Hepatic disorders associated with the use of Ivermectin for SARS-CoV-2 infection in adults: a pharmacovigilance study in VigiBase”, Gastroenterol Hepatol Bed Bench, vol. 15, no. 4, Oct. 2022.